. 2021 May 18;8(4):e1014. doi: 10.1212/NXI.0000000000001014
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1.
High-Risk Antibodies (>70% Associated With Cancer)
